Effect of unani formulation in uterine fibroid.

A CLINICAL STUDY ON THE MANAGEMENT OF UTERINE FIBROID (SALA-E-REHAM) WITH THE UNANI POLYHERBAL FORMULATION- AN OPEN LABEL SINGLE ARM TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104631

Enrollment

Registered

2026-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D259- Leiomyoma of uterus, unspecified

Interventions

Intervention1: 1.Balchad (Nardostachys jatamansi) 2.Murmakki (Commiphora myrrha) 3.Saleekha (Cinnamoum cassia blume) 4. Daalchini (Cinnamomum verum) 5.Izkhar,Rusa grass (Andropogon schoenanthus) 6. Qu

Eligibility

Inclusion criteria

Inclusion criteria: Female between 20-45 years willing to participate Female with uterine fibroid less than and equal to 3cm Haemoglobin of more than or equal to 10 mg per dl

Exclusion criteria

Exclusion criteria: Anatomical defect Patients having history Diabetes, Hypertension, Malignancy and recent Tuberculosis Patients taking Hormonal therapy Menopausal women Women above 45 yrs. Pregnant or lactating women Figo classification 0 and more than 6 Endometrial Hyperplasia

Design outcomes

Primary

Measure	Time frame
Change in the size of uterine fibroid before and after treatment.Timepoint: At baseline and at every 15th day till 90 days	—

Secondary

Measure	Time frame
Improvement in symptoms (pain, tenderness) Pain intensity will be assessed by VAS (Visual Analogue Scale)Timepoint: At baseline and at every 15th day till 90 days	—

Countries

India

Contacts

Public ContactDr Aysha Raza

Ayurvedic and unani Tibbia College and hospital Karol bagh, new delhi - 110005

draysharaza11@gmail.com9354925031

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026